亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)4,4'-二甲氧基三苯基氯甲烷 40615-36-9

 
 
單價(jià) 面議對比
詢價(jià) 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
庫存 1000kg起訂1kg
品牌 盛天恒創(chuàng)
型號(hào) 40615-36-9
規(guī)格 25kg
過期 長期有效
更新 2019-04-19 15:09
 

湖北盛天恒創(chuàng)生物科技有限公司

企業(yè)會(huì)員第13年
資料未認(rèn)證
保證金未繳納
  • 湖北-武漢市
  • 上次登錄 2019-04-19
  • 陳經(jīng)理 (先生)   經(jīng)理
詳細(xì)說明
 4,4'-二甲氧基三苯基氯甲烷
(DMT-CL)
質(zhì)量指標(biāo):
CAS NO.: 40615-36-9 
分子式:C21H19ClO2
分子量:338.83 
外觀:桃花紅色結(jié)晶性粉末 
含量:≥ 98% 
熔點(diǎn):119 -125 ℃  
干燥失重:≤ 0.5% 
用途:生化試劑,核苷合成中的保護(hù)劑。
包裝:化學(xué)純(CP) 20g/鋁箔,工業(yè)級 20kg/紙板桶 
舉報(bào)收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
雷佛奴爾;利凡諾;乳酸依沙吖啶 1837-57-6 供應(yīng)他克莫司 104987-11-3 供應(yīng)維生素C棕櫚酸酯(L-抗壞血酸棕櫚酸酯)137-66-6 供應(yīng)氟蟲腈(非潑羅尼)120068-37-3 供應(yīng)來氟米特(來氟洛米)75706-12-6 供應(yīng)4-(4-氨基苯基)-3-嗎啉酮 438056-69-0 供應(yīng)克拉霉素 81103-11-9
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |